Related Experiment Video

Updated: Jun 9, 2026

Cell Population Analyses During Skin Carcinogenesis
06:53

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

The molecular genetics underlying basal cell carcinoma pathogenesis and links to targeted therapeutics

Julie K Iwasaki1, Divya Srivastava, Ronald L Moy

  • 1Department of Dermatology, Henry Ford Health System, Detroit, Michigan 48202, USA.

Journal of the American Academy of Dermatology
|August 31, 2010
PubMed

Insights

Mutations in the sonic hedgehog pathway drive basal cell carcinoma development. Understanding this pathway offers new targeted treatment strategies for this common skin cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • The sonic hedgehog signaling pathway is crucial for embryonic development.
  • Aberrant activation of this pathway is linked to various cancers, including basal cell carcinoma.
  • Mutations in PTCH1 and SMO genes are primary drivers of basal cell carcinoma pathogenesis.

Purpose of the Study:

  • To review the role of the sonic hedgehog pathway in basal cell carcinoma development.
  • To discuss the implications of pathway misregulation in related syndromes and tumors.
  • To highlight novel targeted therapeutic strategies for basal cell carcinoma.

Main Methods:

  • Literature review of studies on sonic hedgehog signaling in basal cell carcinoma.
  • Analysis of genetic mutations (PTCH1, SMO) and their functional consequences.
  • Synthesis of current understanding of pathway activation and therapeutic targets.

Main Results:

  • Constitutive activation of the sonic hedgehog pathway, driven by PTCH1 and SMO mutations, leads to basal cell carcinoma.
  • Pathway dysregulation is implicated in nevoid basal cell carcinoma syndrome.
  • Targeted therapies aimed at inhibiting the sonic hedgehog pathway show promise.

Conclusions:

  • The sonic hedgehog pathway is a critical determinant in basal cell carcinoma pathogenesis.
  • Targeted inhibition of this pathway represents a promising therapeutic avenue for basal cell carcinoma.
  • Further research into pathway modulation could yield improved treatment outcomes.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...